Ursprung des Netzwerks ersten Grades von Nina Carlén
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 26 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Nina Carlén
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| TAURUS ENERGY AB | Oil & Gas Production | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Top Institute Pharma
 Top Institute Pharma BiotechnologyHealth Technology Part of Center for Translational Molecular Medicine, Top Institute Pharma provides pharmaceutical research services. The private company is based in Leiden, Netherlands. Top Institute Pharma was acquired by Center for Translational Molecular Medicine on June 09, 2015. | Biotechnology | Director/Board Member | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Private Equity Investor Private Equity Investor | |
| ACTIVE BIOTECH AB | Biotechnology | Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
A+ Science Holding AB
 A+ Science Holding AB MiscellaneousMiscellaneous A+ Science Holding AB operates as an investment company, which operates in the field of medical and biotechnology sector. It invests in the life science sector and especially in human medicine. The company was founded in 1997 and is headquartered in Göteborg, Sweden. | Miscellaneous | Director/Board Member Chief Investment Officer Chief Executive Officer | |
| Stockholm School of Economics | College/University | Graduate Degree Undergraduate Degree | |
| University of Uppsala | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Graduate Degree | |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Chairman Corporate Officer/Principal | |
| University of Lund | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
| University of Utrecht | College/University | Doctorate Degree | |
Altimmune UK Ltd.
 Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| University of Gothenburg | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
GU Ventures AB
 GU Ventures AB Investment ManagersFinance GU Ventures AB (GU Ventures) is a venture capital subsidiary of University of Gothenburg founded in 1995. The firm is headquartered in Gothenburg, Sweden. | Investment Managers | Private Equity Investor | |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Private Equity Investor Chairman | |
| BONESUPPORT HOLDING AB | Medical Specialties | Corporate Officer/Principal | |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The private company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Sales & Marketing | |
| Organon International BV | President | ||
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
| I-TECH AB | Chemicals: Major Diversified | Chief Executive Officer Chairman | |
Complix NV
 Complix NV Pharmaceuticals: MajorHealth Technology Complix NVengages in the development of biopharmaceutical company developing Alphabodies, a pipeline of transformative protein therapeutics. The Company is currently focusing its internal research and development activities on oncology and autoimmune diseases. Its therapeutic Alphabodies focuses on the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis and multiple sclerosis, and infectious diseases, and viral diseases such as influenza, HIV, and RSV. The company was founded by Mark Vaeck and Ignace Lasters in 2008 and is headquartered in Diepenbeek, Belgium. | Pharmaceuticals: Major | Chairman | |
InteRNA Technologies BV
 InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Chairman | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Director/Board Member President | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member | |
Cenova AB
 Cenova AB Miscellaneous ManufacturingProducer Manufacturing Cenova AB is a contract manufacturer with 50 years of experience in innovative and complex cleanroom manufacturing of plastic products. The private company is based in Mjölby, Sweden. The Swedish company's focus is on injection molding, vacuum forming, assembly, packaging, and sterilization. The company has the expertise and technology to manufacture products according to the market's toughest standards. The CEO of the company is Fredrik Holmgren. | Miscellaneous Manufacturing | Director/Board Member | |
| Top Sector Life Sciences & Health | Director/Board Member | ||
Asceneuron SA
 Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chairman | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
HealthCap Advisor AB
 HealthCap Advisor AB Investment ManagersFinance HealthCap Advisor AB provides investment advice. The private company is based in Stockholm, Sweden. | Investment Managers | Corporate Officer/Principal | |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Ancilla AB
 Ancilla AB Real Estate DevelopmentFinance Ancilla AB manages real properties. The company is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member | |
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Director/Board Member | |
| Itin Holding AB | Director/Board Member Chairman | ||
| Wntresearch Incentive AB | Director/Board Member Corporate Officer/Principal | ||
| PHARVARIS N.V. | Pharmaceuticals: Major | Founder Director/Board Member | |
| Nefarma | Director/Board Member | ||
| Healthcap Aero Holdings Gp | Director/Board Member | ||
Healthcap Orx Holdings Gp AB
 Healthcap Orx Holdings Gp AB Investment Banks/BrokersFinance Healthcap Orx Holdings Gp AB is a private company that manages securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Trimb Holding AB
 Trimb Holding AB Financial ConglomeratesFinance Part of Karo Healthcare AB, Trimb Holding AB operates as a holding Swedish company with interest in pharmaceuticals. The private company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
Skipjack AB
 Skipjack AB Real Estate DevelopmentFinance Skipjack AB Manages real properties. The company is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member | |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
INIM Pharma AB
 INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member Director/Board Member | |
Therachon Holding GmbH
 Therachon Holding GmbH BiotechnologyHealth Technology Therachon Holding GmbH engages in the acquisition, management, financing, and disposal of participating interests in firms. It also acquires, holds, and disposes intellectual property rights. The company was founded on December 22, 2015 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member |
Statistik
International
| Schweden | 34 |
| Niederlande | 10 |
| Schweiz | 5 |
| Vereinigte Staaten | 3 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 23 |
| Finance | 10 |
| Consumer Services | 7 |
| Commercial Services | 3 |
| Energy Minerals | 2 |
Operativ
| Director/Board Member | 119 |
| Corporate Officer/Principal | 45 |
| Chairman | 34 |
| Chief Executive Officer | 25 |
| Independent Dir/Board Member | 24 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Nina Carlén
- Unternehmensverbindungen
